- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia, Lymphocytic in United States
Total 4649 results
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); FDA Office of Orphan Products DevelopmentCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminated
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompletedChronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Boston Medical CenterCompleted
-
Memgen, LLCCompleted
-
Memgen, LLCCompletedChronic Lymphocytic LeukemiaUnited States
-
Massachusetts General HospitalGenentech, Inc.RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Jennifer WoyachPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Acerta Pharma BVNational Institutes of Health (NIH)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Abcuro, Inc.RecruitingT-cell Large Granular Lymphocytic LeukemiaUnited States
-
Cylene PharmaceuticalsWithdrawnB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedLymphocytic Leukemia, ChronicUnited States, United Kingdom
-
Leslie AndritsosCelgene CorporationCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)TerminatedLarge Granular Lymphocytic Leukemia | LGL LeukemiaUnited States
-
SBI Biotech Co., Ltd.Terminated
-
University of IowaNational Cancer Institute (NCI); Mayo Clinic; PfizerCompletedChronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterGlaxoSmithKlineCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.CompletedLymphoma | LeukemiaUnited States
-
Gilead SciencesApproved for marketingChronic Lymphocytic Leukemia (CLL)United States, Italy, United Kingdom, Ireland
-
Dartmouth-Hitchcock Medical CenterWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Thomas KippsCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Thomas KippsBayerTerminatedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm OncologyCompletedAcute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Minimal Residual Disease | Small Lymphocytic Lymphoma | Acute Biphenotypic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia | CD19 Positive | Blasts 5 Percent or More of Bone Marrow Nucleated CellsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedIdentifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
Joseph TuscanoGlaxoSmithKlineCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompletedLeukemia | Chronic Lymphocytic Leukemia | Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompletedLeukemiaUnited States
-
Massachusetts General HospitalBristol-Myers Squibb; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteGenzyme, a Sanofi CompanyCompletedChronic Lymphocytic LeukemiaUnited States
-
University of PittsburghGenentech, Inc.; BiogenCompletedChronic Lymphocytic LeukemiaUnited States
-
John HaslipCompleted
-
M.D. Anderson Cancer CenterBayerCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBerlex Laboratories, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
University of KentuckyCephalonWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.WithdrawnChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | CLL/SLL | SLLUnited States
-
National Cancer Institute (NCI)TerminatedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | Small Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Advanced CancersUnited States